OKANAUTONI, Angola (Reuters) – Apart from a few packs of medicine and plastic jars, the shelves at the Okanautoni health center in southern Angola are bare and lack basic drugs for saving lives.
(Reuters Health) – Even people with common and often treatable mental health problems like depression and anxiety may have a harder time than patients without these diagnoses getting admitted to a high-quality nursing home, a U.S. study suggests.
(Reuters Health) – Obese people have shorter lives and even those who are just overweight spend more years living with heart disease than individuals who are a healthy weight, a U.S. study suggests.
(Reuters Health) – Even when cutting calories helps people lose weight, they may have a harder time getting rid of excess body fat if they don’t get enough sleep, a small experiment suggests.
BOSTON (Reuters) – The U.S. Food and Drug Administration on Friday took steps to restrict what pharmaceutical ingredients large compounding pharmacies can use to manufacture drugs in bulk that do not go through the agency’s approval processes.
WASHINGTON (Reuters) – U.S. President Donald Trump on Friday said his administration will be suing some drug companies as part of its fight against the opioid drug crisis, without giving more detail.
BOSTON (Reuters) – Alere Inc has agreed to pay $33.2 million to resolve claims it knowingly sold unreliable diagnostic testing devices to hospitals prior to its acquisition by Abbott Laboratories last year, the U.S. Justice Department said on Friday.
STOCKHOLM(Reuters) – Growing numbers of Swedish investors are getting a buzz from trading in listed marijuana stocks even though the country has some of Europe’s most restrictive drug laws.
(Reuters Health) – For women bothered by vaginal symptoms after menopause, prescription local estrogen treatments and expensive specialty lubricants may provide relief, but no more so than a dummy drug, researchers say.
(Reuters) – A panel of European Medicines Agency (EMA) has recommended granting conditional marketing approval to Clovis Oncology’s drug for ovarian cancer, citing anti-tumour activity.